Avac Event

HIV Prevention Re-mix: Current tools, new tools, same goal

Join the UNITED! Movement and AVAC to learn more about the future of HIV prevention and what this means for young people. The webinar will cover:

  • Prevention options currently available
  • Long-acting PrEP products, including those currently available, available soon, and in the pipeline
  • An update on the introduction of six month lenacapavir for PrEP
  • Advocacy priorities for long-acting PrEP research and rollout, with a focus on what these mean for youth
  • Experiences from youth advocates involved with PrEP introduction and rollout

The session will also include time for Q&A with speakers.

Avac Event

South African AIDS Conference (SAAIDS)

The 12th SAAIDS Conference 2025, under the theme: Unite for Change – Empower Communities and Redefine Priorities for HIV/AIDS will be held in Johannesburg 8-11 September.

Resources

If you’re attending, don’t miss a keynote plenary where AVAC’s Mitchell Warren will share perspectives on the future of HIV prevention, and an important satellite on Wednesday, Bridging the Gap and Identifying Opportunities: Innovative Strategies to Accelerate HIV Prevention, Treatment, and Care for Key and Vulnerable Populations in South Africa.  

Avac Event

From Bench to Bedside—Together: Patient-Driven Innovation in Infectious Disease Clinical Trials

AVAC’s Mitchell Warren and Stacey Hannah will join Infectious Disease Alliance (IDA) and Esperity for a webinar on how patient-driven collaboration is enhancing the design, implementation, and impact of clinical trials in the field of infectious diseases. AVAC colleagues will share insights from AVAC’s 30 years of community engagement in HIV prevention.

Avac Event

Reprioritization of Global Fund Programs: What it means  for Community actors in Malaria, Tuberculosis and HIV

The Global Fund is working with Country Coordinating Mechanisms (CCMs) and Principal Recipients (PRs) to reprioritize activities under Grant Cycle 7 (GC7) due to reduced funding allocations. This process aims to safeguard essential HIV, TB, and malaria interventions while promoting integration, cost-effectiveness, and sustainability within broader health programs. Countries are encouraged to consider all available resources, both domestic and external, when making decisions, with GC7 reprioritization laying the groundwork for Grant Cycle 8. The Global Fund urges inclusive stakeholder engagement throughout this process.

As part of this process, the Global Fund encourages inclusive stakeholder engagement. Since the release of the programmatic reprioritization guidance, the Learning Hubs have held joint and regional-level webinars. However, we are now at a critical point where PRs and Country Teams are deep into the reprioritization revisions.

To add value beyond introductory explanations, this webinar will pivot to focus on community-level experiences, with a spotlight on emerging best practices, challenges, and engagement opportunities. This space will enable mutual learning and forward-looking strategising among civil society and community actors.

Objectives

  1. Share community experiences and lessons learned from engaging in the GC7 reprioritization process.
  2. Highlight country-level challenges and best practices around community involvement.
  3. Explore opportunities for communities to strengthen their positioning and influence in the current and future grant cycles.
  4. Provide practical recommendations for better community engagement in grant revision processes.
  5. Inform Global Fund teams on ground-level realities to support more inclusive implementation.

For more information, contact 

  1. Lizzie Otaye(EANNASO) [email protected] 
  2. Dr. Munaymu Ismail (MYCU) [email protected]
  3. Fidele Bemadoum (CS4ME) [email protected] 
  4. Richard Muko (AVAC/COMPASS) [email protected]

Avac Event

IMPT LET’s Talk MPTs “Introducing the Dual Prevention Pill: Lessons Learned and What’s Next for Regulatory, Research, and Rollout” Webinar

Join an engaging session on the Dual Prevention Pill (DPP), featuring Kate Segal (AVAC), Barbara Friedland (Population Council), and Wawira Nyagah (AVAC). Speakers will highlight the product pipeline, the regulatory pathway, and the implementation agenda ahead—followed by a panel discussion with leading experts driving progress in MPTs.

Avac Event

Key Messages from IAS 2025

This webinar will provide participants with scientific, policy, funding and community highlights from IAS 2025, the 13th IAS Conference on HIV Science, held in Kigali, Rwanda, in July. Attendees will gain a clearer understanding of the latest trends and emerging priorities in the global HIV response and hear reflections from stakeholders, including community voices.

Moderators

  • Kenneth Ngure, School of Public Health, Jomo Kenyatta University of Agriculture and Technology and IAS — The International AIDS Society, Kenya
  • Susan Shumba, Young Advocates for Inclusion Network and IAS — The International AIDS Society, Zimbabwe

Speakers

  • Alexandra Calmy, Geneva University Hospitals (HUG) and IAS, Switzerland
  • Gaston Devisich, Fundación Huésped, Argentina
  • Doreen Moraa Moracha, Kenya

Avac Event

New WHO Guidance on Lenacapavir for Prevention & HIV Testing for Long-Acting PrEP

This 60-minute webinar is intended for communities, providers, policy makers and advocates for PrEP, HIV prevention and HIV testing. We will provide an overview of the key takeaways and new guidance from newly released Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis.

Thursday 28 August 2025 at 13:00 – 14:00 Geneva-time

Times in your location: 7:00 EDT / 12:00 WAT / 13:00 CEST / 13:00 SAST / 14:00 EEST / 16:30 IST / 18:00 ICT / 19:00 PHST

After registering, you will receive a confirmation email containing information about joining the webinar.

This is the first webinar in a three-part series: 

  • Part 2 on 4 September 2025 focus on HIV testing (in partnership with PSI)
  • Part 3 will focus on e-training for PrEP providers (in partnership with Jhpiego)

Further details about these webinars will be shared soon!

Avac Event

Expanding HIV Prevention Options: Spotlight on new HIV prevention technologies

Join the International Community of Women Living with HIV Eastern Africa (ICWEA) to discuss the dapivirine vaginal ring, lenacapavir, and cabotegravir. Moderated by Lillian Mworeko and Dr. Lilian Benjamain Mwakyosi, speakers include:

  • Michelle Rodolph, WHO
  • Shannon Kowalski, Global Fund
  • Leonard Solai, Population Council
  • Yvette Raphael, Advocates for the Prevention of HIV in Africa
  • Beryl Abade, youth champion and PrEP advocate

Avac Event

GBGMC Town Hall

We are excited to invite you to our next TOWN HALL 📣 happening on Tuesday, August 12th at 10 AM EST!

We will be launching two critical resources:

  • 📊 Market Assessment Report
  • 📈 Key Population Long-Acting PrEP Demand Forecast

Gain insights from leading voices driving innovation in HIV prevention:

  • ✨ Micheal Ighodaro – GBGMC
  • ✨ Matt Hamilton – Avenir Health
  • ✨ Catherine Verde-Hashim – AVAC

Together, we’ll explore what’s next for long-acting PrEP access, readiness, and demand among key populations globally.

👉 Click the registration link to register now!

Avac Event

Will Lenacapavir be a Lever or a Let-Down? Lessons, Resources and Considerations for Implementation in the United States

Approved in July, lenacapavir for PrEP has tremendous potential to increase access and engagement in the United States, reaching individuals who have been unable to embrace PrEP in its previous formulations. The Choice Agenda and the HIV BLUPrInt team for a deep dive into rolling out lenacapavir (Yeztugo) in the US. Speakers summarized lessons, previewed existing resources, and called for expanded research and practice models that use lenacapavir as a lever to increase HIV prevention access, empowerment, and reach.

Recording / Slides / Resources